SEARCH
Cipla's Umang Vohra on Q2 performance and outlook going forward
CNBC-TV18
2019-11-07
Views
162
Description
Share / Embed
Download This Video
Report
Detailing the third quarter performance and outlook going forward Umang Vohra, MD & Global CEO, Cipla said the trade generic segment has recovered and grew 60 percent versus quarter one. The branded Rx prescription business by 13 percent, he said.
Show more
Share This Video
facebook
google
twitter
linkedin
email
Video Link
Embed Video
<iframe width="600" height="350" src="https://vntv.net//embed/x7nocy8" frameborder="0" allowfullscreen></iframe>
Preview Player
Download
Report form
Reason
Your Email address
Submit
RELATED VIDEOS
05:43
Pidilite Industries on Q2 performance and outlook going forward
05:12
GCPL on Q2 performance and outlook going forward
12:35
BoB on Q3 performance and outlook going forward
12:35
BoB on Q3 performance and outlook going forward
08:16
Hindustan Zinc on Q2 numbers and outlook going forward
02:39
BPCL on Q2 numbers and outlook going forward
07:18
Global Spirits on business outlook going forward
06:18
Newgen Software Technologies: Views & outlook on the business going forward
06:05
Dabur on outlook going forward
21:04
TCS management on Q1 earnigns and outlook going forward
02:33
Bank of India on Q4 performance & trajectory going forward
14:49
Q2 Review: RITES MD On Q2 Performance & Outlook For Upcoming Quarters | BQ Prime
